Literature DB >> 8880577

Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome.

M Wang1, P Kishnani, M Decker-Phillips, S G Kahler, Y T Chen, M Godfrey.   

Abstract

It is now well established that defects in fibrillin-1 (FBN1) cause the variable and pleiotropic features of Marfan syndrome (MFS) and, at the most severe end of its clinical spectrum, neonatal Marfan syndrome (nMFS). Patients with nMFS have mitral and tricuspid valve involvement and aortic root dilatation, and die of congestive heart failure, often in the first year of life. Although mutations in classical MFS have been observed along the entire length of the FBN1 mRNA, mutations in nMFS appear to cluster in a relatively small region of FBN1, approximately between exons 24 and 34. Here we describe the appearance of two FBN1 mutations in a single allele of an infant with nMFS. The changes were within six bases of each other in exon 26. One was a T3212G transversion resulting in an I1071S amino acid substitution and the second was an A3219T transversion resulting in an E1073D amino acid substitution. This is the first reported double mutant allele in FBN1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880577      PMCID: PMC1050731          DOI: 10.1136/jmg.33.9.760

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  33 in total

1.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.

Authors:  H C Dietz; G R Cutting; R E Pyeritz; C L Maslen; L Y Sakai; G M Corson; E G Puffenberger; A Hamosh; E J Nanthakumar; S M Curristin
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

2.  Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains.

Authors:  H C Dietz; J M Saraiva; R E Pyeritz; G R Cutting; C A Francomano
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

3.  Early cardiac manifestations of Marfan's syndrome in the newborn.

Authors:  Z Lababidi; C Monzon
Journal:  Am Heart J       Date:  1981-11       Impact factor: 4.749

4.  Two mutations in Marfan syndrome resulting in truncated fibrillin polypeptides.

Authors:  K Kainulainen; L Y Sakai; A Child; F M Pope; L Puhakka; L Ryhänen; A Palotie; I Kaitila; L Peltonen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

5.  Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene.

Authors:  H C Dietz; R E Pyeritz; E G Puffenberger; R J Kendzior; G M Corson; C L Maslen; L Y Sakai; C A Francomano; G R Cutting
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

6.  Diagnosis and management of infantile marfan syndrome.

Authors:  R P Morse; S Rockenmacher; R E Pyeritz; S P Sanders; F R Bieber; A Lin; P MacLeod; B Hall; J M Graham
Journal:  Pediatrics       Date:  1990-12       Impact factor: 7.124

7.  Complex alleles of the acid beta-glucosidase gene in Gaucher disease.

Authors:  T Latham; G A Grabowski; B D Theophilus; F I Smith
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

8.  The skipping of constitutive exons in vivo induced by nonsense mutations.

Authors:  H C Dietz; D Valle; C A Francomano; R J Kendzior; R E Pyeritz; G R Cutting
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

9.  The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age.

Authors:  H E Sisk; K G Zahka; R E Pyeritz
Journal:  Am J Cardiol       Date:  1983-08       Impact factor: 2.778

10.  A cystic fibrosis allele encoding missense mutations in both nucleotide binding folds of the cystic fibrosis transmembrane conductance regulator.

Authors:  N Kälin; T Dörk; B Tümmler
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

View more
  9 in total

1.  Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues.

Authors:  Russell A Norris; Brook Damon; Vladimir Mironov; Vladimir Kasyanov; Anand Ramamurthi; Ricardo Moreno-Rodriguez; Thomas Trusk; Jay D Potts; Richard L Goodwin; Jeff Davis; Stanley Hoffman; Xuejun Wen; Yukiko Sugi; Christine B Kern; Corey H Mjaatvedt; Debi K Turner; Toru Oka; Simon J Conway; Jeffery D Molkentin; Gabor Forgacs; Roger R Markwald
Journal:  J Cell Biochem       Date:  2007-06-01       Impact factor: 4.429

2.  Two de novo novel mutations in one SHANK3 allele in a patient with autism and moderate intellectual disability.

Authors:  Wenmiao Zhu; Jianli Li; Stella Chen; Jinglan Zhang; Francesco Vetrini; Alicia Braxton; Christine M Eng; Yaping Yang; Fan Xia; Kory L Keller; Leila Okinaka-Hu; Chung Lee; J Lloyd Holder; Weimin Bi
Journal:  Am J Med Genet A       Date:  2018-02-09       Impact factor: 2.802

Review 3.  FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.

Authors:  Lynn Y Sakai; Douglas R Keene; Marjolijn Renard; Julie De Backer
Journal:  Gene       Date:  2016-07-18       Impact factor: 3.688

4.  A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect.

Authors:  Dau-Ming Niu; Betau Hwang; Han-Wei Hwang; Nana H Wang; Jer-Yuarn Wu; Pi-Chang Lee; Jen-Chung Chien; Ru-Chi Shieh; Yuan-Tsong Chen
Journal:  J Med Genet       Date:  2006-05-17       Impact factor: 6.318

5.  Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene.

Authors:  Chantal Stheneur; Gwenaëlle Collod-Béroud; Laurence Faivre; Jean François Buyck; Laurent Gouya; Jean-Marie Le Parc; Bertrand Moura; Christine Muti; Bernard Grandchamp; Gilles Sultan; Mireille Claustres; Philippe Aegerter; Bertrand Chevallier; Guillaume Jondeau; Catherine Boileau
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

6.  Neonatal Marfan Syndrome: Report of a Case with an Inherited Splicing Mutation outside the Neonatal Domain.

Authors:  Laurianne Le Gloan; Quentin Hauet; Albert David; Nadine Hanna; Chloé Arfeuille; Pauline Arnaud; Catherine Boileau; Bénédicte Romefort; Nadir Benbrik; Véronique Gournay; Nicolas Joram; Olivier Baron; Bertrand Isidor
Journal:  Mol Syndromol       Date:  2016-02-02

7.  Detection of rarely identified multiple mutations in MECP2 gene do not contribute to enhanced severity in Rett syndrome.

Authors:  Christopher A Chapleau; Jane Lane; Susan M Kirwin; Carolyn Schanen; Kathy M B Vinette; Danielle Stubbolo; Patrick MacLeod; Daniel G Glaze; Kathleen J Motil; Jeffrey L Neul; Steven A Skinner; Walter E Kaufmann; Alan K Percy
Journal:  Am J Med Genet A       Date:  2013-05-21       Impact factor: 2.802

8.  Congenital diaphragmatic eventration and bilateral uretero-hydronephrosis in a patient with neonatal Marfan syndrome caused by a mutation in exon 25 of the FBN1 gene and review of the literature.

Authors:  Nicole Revencu; Geneviève Quenum; Thierry Detaille; Gaston Verellen; Anne De Paepe; Christine Verellen-Dumoulin
Journal:  Eur J Pediatr       Date:  2003-10-30       Impact factor: 3.183

9.  Dilatation of the great arteries in an infant with marfan syndrome and ventricular septal defect.

Authors:  L Rozendaal; N A Blom; Y Hilhorst-Hofstee; A D J Ten Harkel
Journal:  Case Rep Med       Date:  2011-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.